CVRx, Inc. CVRX
Set alert
1.41 USD -0.02 -1.05%
At close · Oct 30
1.41 0.00 0.00%
After hours · Oct 30, 6:16 PM ET
1.38 Day range 1.46
1.30 52-week range 10.64
- YTD
- -80.14%
- 1 year
- -86.75%
- Open
- 1.41
- Prev close
- 1.43
- Mkt cap
- 37.56M
- Vol
- 272.76K
- Avg vol
- 961.20K
- EPS
- -1.97
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.38
- High
- 1.46
- Forward P/E
- -5.84
- Beta
- 1.11
- Short ratio
- 5.33
- Inst. own
- 71.88%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 23, 2025
- 50-d avg
- 12.92
- 200-d avg
- 11.61
- 1y target
- 18.17
2Y chart
Events in this range
- Nov 4, 2024Rating: Craig-Hallum · Buy → Buy
- Dec 9, 2024Rating: Canaccord Genuity · Buy → Buy
- Jan 23, 2025Earnings: —; estimate -0.38; surprise —%
Signals (89)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| RSI: Oversold | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 7, 2026 | 2 months ago |
| RSI: Oversold | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 30, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 17, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| MACD: Buy Signal | May 26, 2026 | 5 months ago |
| RSI: Oversold | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | May 6, 2026 | 5 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 22, 2026 | 6 months ago |
| SMA: Bearish | Apr 15, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Apr 9, 2026 | 6 months ago |
| SMA: Bearish | Apr 8, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 6, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 17, 2026 | 7 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 13, 2026 | 7 months ago |
| SMA: Bearish | Mar 12, 2026 | 7 months ago |
| SMA: Bullish | Mar 11, 2026 | 7 months ago |
| SMA: Bearish | Mar 10, 2026 | 7 months ago |
| SMA: Bullish | Feb 25, 2026 | 8 months ago |
| SMA: Bullish | Feb 24, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| RSI: Oversold | Feb 13, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 11, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 23, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 13, 2026 | 9 months ago |
| RSI: Oversold | Jan 13, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 6, 2026 | 9 months ago |
| RSI: Oversold | Dec 26, 2025 | 10 months ago |
| SMA: Bearish | Dec 17, 2025 | 10 months ago |
| SMA: Bullish | Dec 16, 2025 | 10 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| SMA: Bearish | Dec 2, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 1, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| SMA: Bullish | Nov 21, 2025 | 11 months ago |
| SMA: Bearish | Nov 20, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 15, 2025 | 1 year ago |
| RSI: Overbought | Oct 15, 2025 | 1 year ago |
| RSI: Overbought | Oct 8, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 15, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 26, 2025 | 1 year ago |
| SMA: Bullish | Aug 19, 2025 | 1 year ago |
| SMA: Bearish | Aug 18, 2025 | 1 year ago |
| SMA: Bullish | Aug 6, 2025 | 1 year ago |
| SMA: Bearish | Aug 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 31, 2025 | 1 year ago |
| RSI: Overbought | Jul 16, 2025 | 1 year ago |
| SMA: Bullish | Jul 2, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 13, 2025 | 1 year ago |
| MACD: Buy Signal | May 15, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| RSI: Oversold | May 9, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 28, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 8, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 18, 2025 | 1 year ago |
| RSI: Oversold | Mar 13, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 19, 2025 | 1 year ago |
| SMA: Bullish | Feb 14, 2025 | 1 year ago |
| SMA: Bearish | Feb 11, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 31, 2025 | 1 year ago |
| RSI: Overbought | Jan 23, 2025 | 1 year ago |
| RSI: Overbought | Jan 14, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 27, 2024 | 1 year ago |
Key statistics
- Market cap
- 303.30M
- Enterprise value
- 244.11M
- Trailing P/E
- 0.00
- Forward P/E
- -5.84
- PEG ratio
- 0.00
- Price / sales
- 6.42
- Price / book
- 4.64
- EPS (TTM)
- -2.69
- Beta
- 1.11
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -123.75%
- Revenue (TTM)
- 47.26M
- Revenue growth
- 27.20%
- Free cash flow
- -21.40M
- Total cash
- 100.16M
- Total debt
- 50.44M
- Return on equity
- -79.02%
- Shares outstanding
- 24.26M
- Short % of float
- 12.35%
- 50-day average
- 12.92
- 200-day average
- 11.61
Analyst view
Consensus: buy
Buy
Price target (mean) 18.17 +1188.4% upside
Now 1.41
- Target (low)
- 13.00
- Target (mean)
- 18.17
- Target (high)
- 22.00
Ratings (0m) 7 5 buy · 2 hold · 0 sell
- Strong buy1
- Buy4
- Hold2
- Sell0
- Strong sell0
Next earnings
Jan 23, 2025
Expected Jan 23, 2025. Consensus EPS estimate -0.38393.
Financials — quick view
CVRX Revenue — quarterly 15.71M
CVRX Net income — quarterly -14.04M
CVRX EPS — quarterly -0.53
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 23, 2025 | Dec 1, 2024 | -0.38 | — | — | — |
| Oct 29, 2024 | Sep 1, 2024 | -0.45 | -0.57 | -0.12 | -26.67% |
| Jul 29, 2024 | Jun 1, 2024 | -0.51 | — | — | — |
| Jul 29, 2024 | Jun 1, 2024 | -0.51 | -0.65 | -0.14 | -27.45% |
| Apr 30, 2024 | Mar 1, 2024 | -0.53 | — | — | — |
| Apr 30, 2024 | Mar 1, 2024 | -0.53 | -1.04 | -0.51 | -96.23% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 9, 2024 | Canaccord Genuity | main | Buy | Buy |
| Nov 4, 2024 | Craig-Hallum | main | Buy | Buy |
| Oct 30, 2024 | Lake Street | main | Buy | Buy |
| Oct 30, 2024 | Canaccord Genuity | main | Buy | Buy |
| Oct 30, 2024 | Piper Sandler | reit | Overweight | Overweight |
| Oct 23, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
About CVRx, Inc.
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- cvrx.com
News
- CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
- CVRx Reports Q2 2026 Results: Full Earnings Call Transcript
- HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- CVRx To Present Barostim Data And Clinical Research At HFSA Annual Scientific Meeting 2026
- CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
- HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop
- CVRx Appoints John Landry CFO, Effective Oct. 12, Succeeding Jared Oasheim
- CVRx Appoints John Landry as Chief Financial Officer
- HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop
Your note
Sign in to keep a note on CVRX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEHBAHANI ALI | Director | Conversion of Exercise of derivative security | Dec 13, 2023 | 316 |
| GALLE LIZ | Officer | Conversion of Exercise of derivative security | Oct 15, 2023 | 778 |
| HYKES KEVIN | Chief Executive Officer | Purchase | Aug 4, 2024 | 30,000 |
| JOHNSON & JOHNSON INNOVATION - JJDC, INC. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 28, 2024 | 0 |
| OASHEIM JARED | Chief Financial Officer | Conversion of Exercise of derivative security | Sep 17, 2023 | 15,447 |
| PALMER CRAIG E | Officer | Conversion of Exercise of derivative security | Mar 24, 2024 | 1,229 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Johnson & Johnson | 16.91% | 4,103,430 | 51.29M | Sep 29, 2024 |
| NEA Management Company, LLC | 9.77% | 2,370,542 | 29.63M | Sep 29, 2024 |
| Blackrock Inc. | 3.75% | 909,423 | 11.37M | Sep 29, 2024 |
| Vanguard Group Inc | 3.40% | 824,290 | 10.30M | Sep 29, 2024 |
| Parkman Healthcare Partners LLC | 2.81% | 682,897 | 8.54M | Sep 29, 2024 |
| Schonfeld Strategic Advisors Llc | 2.25% | 545,300 | 6.82M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.24% | 544,348 | 6.80M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.40% | 338,536 | 4.23M | Oct 30, 2024 |
| College Retirement Equities Fund-Stock Account | 0.69% | 167,840 | 2.10M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.68% | 165,802 | 2.07M | Sep 29, 2024 |
| Trust for Professional Managers-Mairs & Power Small Cap Fund | 0.59% | 142,456 | 1.78M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.56% | 136,885 | 1.71M | Aug 30, 2024 |